Skip to content
ES
MARKETS / NYSE / HLN
NYSE · PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS · LARGE CAP

Haleon PLC HLN

6 fiscal years on record · GBP · FY2025 reported · SEC filings only
£11.0B
▼ 1.8% YoY
£1.7B
▲ 15.6% YoY
£2.3B
▲ 12.7% YoY
In brief

What this company does

The Group sells Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other products, with a product portfolio that is consistent across its reportable segments. Throughout 2025, the Group was organised into business units based on geographical areas, with three reportable segments: North America, Europe, Middle East, Africa and Latin America (EMEA & LatAm), and Asia Pacific (APAC). North America generated revenue of £3,866 million in 2025. EMEA & LatAm generated revenue of £4,592 million in 2025. APAC generated revenue of £2,572 million in 2025.

Written from the business description in Haleon plc's annual report to the U.S. Securities and Exchange Commission, filed 13 March 2026. Every sentence was checked against that document before publication.

Growth
GBP 11.0B
Revenue, FY2025 · full 6-year series below
Revenue £B Net income £B
FY2025 · Revenue 11.0 · Net income 1.7
4B8B202020212022202320242025
Compound annual growth
+0.5%
+2.2%
+16.3%
+7.8%
+17.2%
+8.3%
−60.0%
−20.3%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +2.2% a year over five years — but profit grew faster: net income at +7.8%, earnings per share at +8.3%.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
15 cents
of every revenue dollar became profit
Operating margin Net margin
FY2025 · Operating 21.9% · Net 15.2%
10%20%202020212022202320242025
ROE
FY2025 · ROE 10.2%
5%10%202020212022202320242025
Gross margin64.2%
Operating margin21.9%
Net margin15.2%
Return on assets5.0%
EBITDAGBP 2.8B

Each GBP of equity produced 10 cents of profit this year.

Cash & shareholders
GBP 763.0M
returned in FY2025 · dividends + net buybacks
Free cash flow £B
FY2025 · FCF 2.3
0.8B1.6B202020212022202320242025
Net buybacks £B Dividends £B
FY2025 · Dividends 0.6 · Net buybacks 0.2
4B8B202020212022202320242025
Dividends paidGBP 612.0M
Net buybacksGBP 151.0M
Share of profit45.8%
Consecutive raises1 years

GBP 612.0M in dividends and GBP 151.0M in buybacks — 46% of the year's profit went back to shareholders.

Total assetsGBP 32.6B
EquityGBP 16.4B
CashGBP 1.3B
Gross debtGBP 8.6B
Net debtGBP 7.3B
Current ratio0.92×

Net debt stands at 44% of equity.

The 6-year record
6 fiscal years
Every figure from documents filed with the SEC · GBP
row low → row highnegative
Metric 202520242023202220212020
Revenue £B11.011.211.310.99.59.9
Operating income £B2.42.22.01.81.61.6
EBITDA £B2.82.52.3···
Income tax £B0.50.40.50.50.20.4
Net income £B1.71.41.01.11.41.1
Free cash flow £B2.32.11.91.81.11.2
EPS, diluted £0.180.160.110.120.150.12
Dividend / sh £···11930.001148.002371.00
Payout %374037112583207
ROE %10.28.86.45.05.3·
Shares out B8.959.089.23···

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 28 reconciliationsAUDITED

Reconciled in 6 of 19 fiscal years. 67 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityPerfumes, Cosmetics & Other Toilet Preparations
Listed onNYSE
Incorporated inoutside the United States — SEC code X0
Fiscal year endsDecember 31
Data on record since2020

Share this section

Download image